SEC-sourced researchBeta
NWBO
NORTHWEST BIOTHERAPEUTICS INC
Company comparison ↗
Data passport
- CIK
- 0001072379
- Exchange
- OTC
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Apr 15, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 1,382,000.0000 | Apr 15, 2026 |
| December 2025 | 1,378,000.0000 | Apr 15, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,378,000.0000 | -60,162,000.0000 | -44,763,000.0000 | 81,290,000.0000 | 128,860,000.0000 | Apr 15, 2026 |
| December 2024 | 1,382,000.0000 | -83,778,000.0000 | -57,017,000.0000 | 26,728,000.0000 | 105,708,000.0000 | Apr 15, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.38M | December 2025 | Apr 15, 2026 | 10-K |
| Previous period revenueRevenueFromContractWithCustomerExcludingAssessedTax | $1.38M | December 2024 | Apr 15, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$60.16M | December 2025 | Apr 15, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$44.76M | December 2025 | Apr 15, 2026 | 10-K |
| Total assetsAssets | $81.29M | December 2025 | Apr 15, 2026 | 10-K |
| Total liabilitiesLiabilities | $128.86M | December 2025 | Apr 15, 2026 | 10-K |